A. Rachel Leheny
CIK 1484729 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$275.6K
Companies
4
Total Filings
27
Lifetime Open-Market Net
$914.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | CHIEF EXECUTIVE OFFICER | 383,883 | $0.72 | $275.6K | $85.1K | 20 | 2026-06-29 |
| CalciMedica, Inc. (SCPH) Delisted | CHIEF EXECUTIVE OFFICER | 197,154 | $5.67 | $1.12M | $79.2K | 3 | 2024-11-01 |
| CalciMedica, Inc. (GRAY) Delisted | Chief Executive Officer | 356,989 | $5.50 | $1.96M | $0 | 1 | 2023-03-22 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | 22,248 | — | — | $750.0K | 3 | 2010-10-04 |
Recent Filings · Page 3 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-24 | CALC | Buy (P) | +3,000 | $10.0K | EDGAR |
| 2023-05-18 | CALC | Buy (P) | +1,000 | $2.7K | EDGAR |
| 2023-05-10 | CALC | Grant (A) | — | $0 | EDGAR |
| 2023-03-22 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | +739,326 | $0 | EDGAR |
| 2010-10-04 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-09-24 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Buy (P) | +250,000 | $750.0K | EDGAR |
| 2010-03-05 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Mixed | +1,173,896 | $3.76M | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.